These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 34504310)
21. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease. McAlinden KD; Eapen MS; Lu W; Sharma P; Sohal SS Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L585-L595. PubMed ID: 32726146 [TBL] [Abstract][Full Text] [Related]
28. Electronic cigarettes and e-cigarette/vaping product use associated lung injury (EVALI). Shinbashi M; Rubin BK Paediatr Respir Rev; 2020 Nov; 36():87-91. PubMed ID: 32653465 [TBL] [Abstract][Full Text] [Related]
29. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. Sahebnasagh A; Saghafi F; Safdari M; Khataminia M; Sadremomtaz A; Talaei Z; Rezai Ghaleno H; Bagheri M; Habtemariam S; Avan R J Clin Pharm Ther; 2020 Dec; 45(6):1515-1519. PubMed ID: 32860252 [TBL] [Abstract][Full Text] [Related]
30. Lung Biopsy Findings in Severe Pulmonary Illness Associated With E-Cigarette Use (Vaping). Mukhopadhyay S; Mehrad M; Dammert P; Arrossi AV; Sarda R; Brenner DS; Maldonado F; Choi H; Ghobrial M Am J Clin Pathol; 2020 Jan; 153(1):30-39. PubMed ID: 31621873 [TBL] [Abstract][Full Text] [Related]
31. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study. Blagev DP; Harris D; Dunn AC; Guidry DW; Grissom CK; Lanspa MJ Lancet; 2019 Dec; 394(10214):2073-2083. PubMed ID: 31711629 [TBL] [Abstract][Full Text] [Related]
32. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial. Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785 [TBL] [Abstract][Full Text] [Related]
36. "Tree-in-Bloom": Severe Acute Lung Injury Induced by Vaping Cannabis Oil. He T; Oks M; Esposito M; Steinberg H; Makaryus M Ann Am Thorac Soc; 2017 Mar; 14(3):468-470. PubMed ID: 28248584 [No Abstract] [Full Text] [Related]
38. E-cigarette or vaping product use-associated acute lung injury (EVALI) as a therapeutic problem in anaesthesiology and intensive care departments. Bizoń M; Maciejewski D; Kolonko J Anaesthesiol Intensive Ther; 2020; 52(3):219-225. PubMed ID: 32876409 [TBL] [Abstract][Full Text] [Related]
39. Vaping-Related Acute Parenchymal Lung Injury: A Systematic Review. Jonas AM; Raj R Chest; 2020 Oct; 158(4):1555-1565. PubMed ID: 32442559 [TBL] [Abstract][Full Text] [Related]
40. Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products. Kapandji N; Yvin E; Devriese M; de Margerie-Mellon C; Moratelli G; Lemiale V; Jabaudon M; Azoulay E; Constantin JM; Dumas G Am J Respir Crit Care Med; 2021 Aug; 204(3):359-362. PubMed ID: 34033529 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]